Alzheimers drug by Biogen

Controversy around the newly approved Alzheimer’s drug by Biogen

Aduhelm is the first drug approved for Alzheimer’s since 2003, which has immediately become a controversy. While some call it a breakthrough, there are experts who consider the evidence is not good enough for the FDA approval. Aducanumab is its generic name which was granted accelerated approval. Alzheimer’s disease is often referred as a devastating…